lysophosphatidic acid has been researched along with Ascites in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Duan, C; He, Z; Huang, J; Li, B; Li, J; Li, L; Liu, W; Liu, Y; Lu, J; Tang, Y; Wang, Q; Zeng, R; Zeng, S; Zhong, M; Zhou, L | 1 |
| Asafova, A; Brandt, DT; Finkernagel, F; Graumann, J; Grosse, R; Jansen, JM; Konzer, A; Lieber, S; Müller, R; Müller-Brüsselbach, S; Nist, A; Nockher, WA; Pesek, J; Reinartz, S; Stiewe, T; Wagner, U; Watzer, B; Worzfeld, T | 1 |
| Aoki, J; Emoto, S; Igarashi, K; Ikeda, H; Kano, K; Kitayama, J; Kurano, M; Matsusaki, K; Nishikawa, M; Yamashita, H; Yatomi, Y | 1 |
| Bigsby, RM; Caperell-Grant, A; Liu, J; Mok, SC; Wang, D; Xu, Y; Yang, G; Zhao, Z | 1 |
| Bae, SS; Birnbaum, MJ; Cho, M; Do, KH; Kim, CD; Kim, EK; Kim, JH; Kim, MS; Suh, DS; Yun, SJ | 1 |
| Im, DS; Kimura, T; Komachi, M; Kurose, H; Kuwabara, A; Malchinkhuu, E; Mogi, C; Ohta, H; Okajima, F; Sato, K; Takeyoshi, I; Tobo, M; Tomura, H; Yamada, T | 1 |
| Barbolina, MV; Burkhalter, RJ; Forgacs, G; Hudson, LG; Liu, Y; Marga, F; Moss, NM; Stack, MS; Westfall, SD | 1 |
| Im, DS; Ishii, S; Kimura, T; Komachi, M; Mogi, C; Ohta, H; Okajima, F; Sato, K; Takeyoshi, I; Tobo, M; Tomura, H; Yamada, T; Yanagida, K | 1 |
| Antalis, C; Cai, Q; Del Priore, G; Hamed, AH; Schilder, JM; Stehman, FB; Xu, Y; Yan, L; Zhao, Z | 1 |
| Kitayama, J; Nagawa, H; Ohta, H; Sakai, T; Sako, A; Shida, D; Suzuki, R | 1 |
| Bast, RC; Fang, X; Lee, Z; Liang, Y; Liu, S; Lu, KH; Mills, GB; Swaby, RF; Yu, S | 1 |
| Chang, CL; Cho, M; Jeon, ES; Kim, JH; Lee, JS; Lee, MJ; Suh, DS | 1 |
| Chang, CL; Cho, M; Jeon, ES; Jung, JS; Kim, JH; Kim, YM; Lee, MJ; Moon, HJ; Song, HY; Suh, DS; Yoon, MS | 1 |
| Horita, Y; Inoue, M; Mizuno, K; Mukai, M; Ohashi, K | 1 |
1 review(s) available for lysophosphatidic acid and Ascites
| Article | Year |
|---|---|
Microenvironmental regulation of ovarian cancer metastasis.
Topics: Ascites; Cadherins; Carcinoma; Cell Adhesion; Cell Dedifferentiation; Cell Differentiation; Cell Transformation, Neoplastic; Cytokines; Epithelial Cells; Extracellular Matrix; Female; Fibroblasts; Humans; Inflammation; Integrins; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Neoplasm Proteins; Ovarian Neoplasms; Peptide Hydrolases; Peritoneal Neoplasms; Phenotype | 2009 |
13 other study(ies) available for lysophosphatidic acid and Ascites
| Article | Year |
|---|---|
Lysophosphatidic Acid is a Biomarker for Peritoneal Carcinomatosis of Gastric Cancer and Correlates with Poor Prognosis.
Topics: Adult; Aged; Ascites; Biomarkers, Tumor; China; Disease-Free Survival; Female; Humans; Lysophospholipids; Male; Middle Aged; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms | 2017 |
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
Topics: Ascites; Cell Line, Tumor; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Lysophospholipids; Macrophages; Metabolome; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Receptors, Lysophosphatidic Acid; Signal Transduction; Treatment Outcome; Tumor Microenvironment; Up-Regulation | 2019 |
Analysis of glycero-lysophospholipids in gastric cancerous ascites.
Topics: Animals; Ascites; Female; Fibrosis; Humans; Lysophospholipids; Male; Mice; Phospholipases A1; Phosphoric Diester Hydrolases; Stomach Neoplasms | 2017 |
S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells.
Topics: Ascites; Cell Line, Tumor; Cell Movement; Cell Shape; Enzyme Activation; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Lysophospholipids; Mitogen-Activated Protein Kinase Kinases; Ovarian Neoplasms; Protein Kinase C; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Stress Fibers | 2008 |
Lysophosphatidic acid induces cell migration through the selective activation of Akt1.
Topics: Adult; Aged; Animals; Ascites; Cell Movement; Cells, Cultured; Embryo, Mammalian; Enzyme Activation; Female; Humans; Liver Cirrhosis; Lysophospholipids; Mice; Middle Aged; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Pregnancy; Proto-Oncogene Proteins c-akt; Substrate Specificity | 2008 |
LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Topics: Ascites; Cell Line, Tumor; Cell Movement; Collagen; Drug Combinations; Epidermal Growth Factor; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Isoxazoles; Laminin; Lysophospholipids; Neoplasm Invasiveness; Pancreatic Neoplasms; Pertussis Toxin; Propionates; Proteoglycans; Receptors, Lysophosphatidic Acid; rhoA GTP-Binding Protein; RNA, Small Interfering | 2009 |
Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Topics: Animals; Ascites; Cell Line, Tumor; Cell Movement; Humans; Isoxazoles; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Peritoneal Neoplasms; Propionates; Receptors, Lysophosphatidic Acid; Xenograft Model Antitumor Assays | 2012 |
Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.
Topics: Animals; Arachidonic Acids; Ascites; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Lysophospholipids; Mice; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Organophosphonates; Ovarian Neoplasms; Phospholipases A2, Secretory; Phosphoric Diester Hydrolases; Transplantation, Heterologous | 2012 |
Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.
Topics: Animals; Ascites; Cell Line, Tumor; Culture Media, Conditioned; Disease Models, Animal; Epithelial Cells; Epithelium; Female; Humans; Isoxazoles; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, Nude; Pertussis Toxin; Propionates; Receptors, Lysophosphatidic Acid; RNA, Messenger; Stomach Neoplasms; Vascular Endothelial Growth Factor A | 2006 |
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Topics: Ascites; Cell Line, Tumor; Chemokine CXCL1; Chemokines, CXC; Down-Regulation; Female; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Intercellular Signaling Peptides and Proteins; Isoxazoles; Lysophospholipids; Ovarian Neoplasms; Pertussis Toxin; Propionates; Receptors, Lysophosphatidic Acid; Transcriptional Activation | 2006 |
Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells.
Topics: Ascites; Calcium; Cell Movement; Cells, Cultured; Female; Humans; Lysophospholipids; Mesenchymal Stem Cells; Ovarian Neoplasms; Peritoneal Neoplasms; rhoA GTP-Binding Protein | 2008 |
Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells.
Topics: Actins; Adipocytes; Adult; Aged; Animals; Ascites; Autocrine Communication; Cell Differentiation; Chemokine CXCL12; Female; Fibroblasts; Humans; Lysophospholipids; Mesenchymal Stem Cells; Middle Aged; Ovarian Neoplasms; Rats; Receptors, Lysophosphatidic Acid; Smad2 Protein; Smad3 Protein; Stem Cells; Transforming Growth Factor beta1 | 2008 |
Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase.
Topics: Actin Depolymerizing Factors; Actins; Animals; Ascites; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cytoskeleton; Destrin; Epithelium; Focal Adhesions; Lim Kinases; Lysophospholipids; Microfilament Proteins; Neoplasm Invasiveness; Neoplasm Proteins; Phosphoric Monoester Hydrolases; Phosphorylation; Rats; RNA, Small Interfering | 2008 |